CCRAS Highlights Pediatric ADR Vigilance on World Patient Safety Day

Date:

Share post:

CCRAS Highlights Pediatric ADR Vigilance on World Patient Safety

PharmaGenDRx News Bureau- 22nd September,2025

2:00 PM IST

To mark World Patient Safety Day 2025, the central Council for Research in Ayurvedic Sciences (CCRAS), Ministry of Ayush organized a two day National Symposium on“Pharmacovigilance- Sishu Suraksha: Rashtra Suraksha” at LNIPES, Gwalior. The event,hosted through the Regional Ayurveda Research Institute (RARI), Gwalior in collaboration with the National Pharmacovigilance Coordination Centre for AYUSH Drugs, All India Institute of Ayurveda (AIIA), New Delhi, focused on strengthening vigilance against Adverse Drug Reactions (ADRs) in children.

The symposium was inaugurated by Prof.(Dr.) B.L. Mehra, Chairman, NCISM, New Delhi who underlined the significance of child safety in Ayurveda and lauded CCRAS for choosingsuch a timely theme. Distinguished experts including Prof.(Dr.) Rabinarayan Acharya,Director General, CCRAS; Dr. N. Srikanth, Deputy DG, CCRAS and Prof. Bejon Kumar Mishra emphasized the moral obligation of ensuring safe pediatric care and the role of pharmacovigilance in protecting young patients.

For the first time, the symposium carried NCISM approved CME credit scores. Over eight scientific sessions, more than 28 research papers and 31 posters were presented by PG/PhD scholars, faculty and research officers covering diverse aspects of pediatric safety and Ayurveda practice. Eminent academicians from reputed institutes across the country enriched the discussions with their insights.

The event was attended by over 150 Ayurveda physicians, researchers and scholars who reinforced the message for ensuring safe care for every newborn and child ensures stronger national health.

By Arundhuti Chatterjee & Sharon Bose

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...